161 related articles for article (PubMed ID: 711437)
1. Complications of the new contraceptive preparations.
Clinch J
Ir Med J; 1978 Oct; 71(15):513-4. PubMed ID: 711437
[No Abstract] [Full Text] [Related]
2. [Oral contraceptives: update].
Fugère P
Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
[No Abstract] [Full Text] [Related]
3. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
Drill VA
J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
[TBL] [Abstract][Full Text] [Related]
4. [Liver cell tumor induction by oral contraceptives].
Gräf KJ; Meyer zum Büschenfelde KH
Dtsch Med Wochenschr; 1980 Jan; 105(2):61-5. PubMed ID: 6766098
[No Abstract] [Full Text] [Related]
5. Re: Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
Schilling LH
Contraception; 2009 Mar; 79(3):241; author reply 241-2. PubMed ID: 19185682
[No Abstract] [Full Text] [Related]
6. Oral contraceptives and the risk of cardiovascular disease.
Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850
[TBL] [Abstract][Full Text] [Related]
7. [Venous pathology with estrogens-progestagens].
Vin F; Allaert FA; Levardon M
Phlebologie; 1989; 42(3):473-9; discussion 479-80. PubMed ID: 2626469
[No Abstract] [Full Text] [Related]
8. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices.
Ober WB
Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919
[No Abstract] [Full Text] [Related]
9. [Synthetic estroprogestatives and phlebology. Introduction].
Muller P
Phlebologie; 1972; 25(3):223-6. PubMed ID: 4662045
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive agents and the glucose tolerance problem.
Cohn RE
Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284
[No Abstract] [Full Text] [Related]
11. Letter: Withdrawal of Serial C.
Heber KR
Med J Aust; 1976 Mar; 1(12):412. PubMed ID: 1272128
[TBL] [Abstract][Full Text] [Related]
12. Complications of systemic contraceptive agents: hypertension.
Wolfsen AR
West J Med; 1975 Jan; 122(1):38-40. PubMed ID: 1089005
[No Abstract] [Full Text] [Related]
13. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations].
Osler M
Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492
[No Abstract] [Full Text] [Related]
14. [Review of side effects of oral contraceptives].
Janssens J
Nature; 1970 Jul; 227(5256):1418-22. PubMed ID: 5448324
[No Abstract] [Full Text] [Related]
15. [Trends in drug-hormone contraception].
Kuemmerle HP
Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):465-6. PubMed ID: 5718773
[No Abstract] [Full Text] [Related]
16. Safety of oral contraceptives related to steroid content: a critical review.
Sturtevant FM
Int J Fertil; 1989; 34(5):323-32. PubMed ID: 2571592
[TBL] [Abstract][Full Text] [Related]
17. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Shapiro S
Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
[No Abstract] [Full Text] [Related]
18. [Choice of ovulation inhibitors].
Mall-Haefeli M
Ther Umsch; 1970 Oct; 27(10):652-9. PubMed ID: 5512723
[No Abstract] [Full Text] [Related]
19. Estrogens, progestogens and breast cancer.
Sturgis SH
N Engl J Med; 1969 Oct; 281(18):1014-5. PubMed ID: 5824728
[No Abstract] [Full Text] [Related]
20. [Reflexions on a new generation of oral contraceptives].
Gaspard U
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):85-92. PubMed ID: 4008893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
